|Printable version||E-mail this to a friend|
Cancer Research UK - New way of testing drugs could speed up development of breast cancer treatments
Scientists have discovered a new way to test hundreds of cancer drugs very quickly, which could drastically cut the time it takes to find potential breast cancer treatments, according to a Cancer Research UK-funded study published in Cell.
The researchers found they could do this by growing human tumour cells in mice before taking the cells out to run further tests using experimental drugs.
Cells grown in this way more accurately mimic how cancer cells grow in a person’s body and closely reflect the genetic faults found in patients’ cancer cells. This method means more drugs could be tested at the same time and in different combinations, potentially shortening the time it takes to make new drugs available to patients.
This new technique means that researchers can carry out hundreds of drug tests after removing the cancer cells from mice. It is set to replace current practice of growing cancer cells on plastic dishes and transferring them to mice to carry out tests – an approach which has limitations because tumour cells grow differently in a plastic dish than in the human body.
Professor Carlos Caldas(link is external), lead author based at the Cancer Research UK Cambridge Institute at the University of Cambridge, said: “Traditionally, we’ve grown cells on plastic dishes but this is artificial because cells in the body grow in a more complicated way. In the future, this new technique, and others like it, will replace the methods used in the lab today.
“We’re making all our data publically available so that other researchers around the world can use and benefit from our work and we’ll continue to improve it.”
Nell Barrie, Cancer Research UK’s senior science information manager, said: “Finding new ways to test potential drugs more accurately and efficiently is really important in the fight against cancer. Studies like this could help us find new treatments more quickly and might also help identify the best combinations of drugs for particular groups of patients, ensuring more people survive the disease.”
For media enquiries please contact the Cancer Research UK press office on +44 203 469 8300 or, out-of-hours, the duty press officer on +44 7050 264 059.
Bruna et al., A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds. Cell, 2016.
Latest News from
Cancer Research UK - 1 in 5 emergency bowel cancer patients had symptoms before diagnosis29/09/2016 14:35:00
Around one in five bowel cancer patients diagnosed after an emergency presentation have displayed at least one cancer ‘alarm symptom’ in the year leading up to their diagnosis, according to a Cancer Research UK-funded study (link is external) published in the British Journal of Cancer (link is external).
BHF - Common prescription painkillers linked to increased risk of heart failure29/09/2016 12:35:00
A study has found that commonly used prescribed painkillers, used to treat pain and inflammation, are associated with an increased risk of hospitalisation for heart failure.
Cancer Research UK - Low cancer symptom awareness linked to lower chance of survival29/09/2016 10:35:00
In regions where cancer survival is poorer, people on average have lower awareness of cancer symptoms, according to new findings (link is external) published yesterday in the British Journal of Cancer(link is external)*.
Cancer Research UK - Precision medicine trial first of its kind to show benefit to patients28/09/2016 08:15:00
A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine – or tailoring treatment for individual people – can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference(link is external), last week.